Sign In
Buy NTLA
Intellia Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 38.63. In total, the insiders bought 2.98M and sold 210.23K NTLA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
38.63 |
| ● Buy | 2.98M shares |
| ● Sell | 210.23K shares |
|
69% Buy Activity
Moderate Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 29, 2025 Sell |
Bhanji Muna Director |
265 Value: $2K |
||
|
Mar 04, 2025 Sell |
Clark Eliana EVP, Chief Technical Officer |
679 Value: $6K |
||
|
Mar 04, 2025 Sell |
Basta James EVP, General Counsel |
2 572 Value: $23.1K |
||
|
Mar 04, 2025 Sell |
Clark Eliana EVP, Chief Technical Officer |
679 Value: $6K |
||
|
Mar 01, 2025 Buy |
Clark Eliana EVP, Chief Technical Officer |
32 000 Value: $416.6K |
||
|
Mar 01, 2025 Buy |
Clark Eliana EVP, Chief Technical Officer |
45 714 Value: $461.3K |
||
|
Mar 01, 2025 Buy |
Leonard John M President And CEO |
136 000 Value: $1.77M |
||
|
Mar 01, 2025 Buy |
Leonard John M President And CEO |
196 000 Value: $1.98M |
||
|
Mar 01, 2025 Buy |
Dulac Edward J Iii EVP, Chief Financial Officer |
47 200 Value: $614.5K |
||
|
Mar 01, 2025 Buy |
Dulac Edward J Iii EVP, Chief Financial Officer |
67 429 Value: $680.4K |
||
|
Mar 01, 2025 Buy |
Dube Michael P Vp, Chief Accounting Officer |
14 000 Value: $182.3K |
||
|
Mar 01, 2025 Buy |
Lebwohl David EVP, Chief Medical Officer |
43 200 Value: $562.5K |
||
|
Mar 01, 2025 Buy |
Lebwohl David EVP, Chief Medical Officer |
61 714 Value: $622.7K |
||
|
Mar 01, 2025 Buy |
Schultes Birgit C EVP, Chief Scientific Officer |
37 600 Value: $489.6K |
||
|
Mar 01, 2025 Buy |
Schultes Birgit C EVP, Chief Scientific Officer |
53 714 Value: $542.0K |
||
|
Mar 01, 2025 Buy |
Basta James EVP, General Counsel |
40 000 Value: $520.8K |
||
|
Mar 01, 2025 Buy |
Basta James EVP, General Counsel |
57 143 Value: $576.6K |
||
|
Mar 01, 2025 Buy |
Lebwohl David EVP, Chief Medical Officer |
61 714 Value: $622.7K |
||
|
Mar 01, 2025 Buy |
Lebwohl David EVP, Chief Medical Officer |
43 200 Value: $562.5K |
||
|
Mar 01, 2025 Buy |
Dube Michael P Vp, Chief Accounting Officer |
14 000 Value: $182.3K |
||
|
Mar 01, 2025 Buy |
Dulac Edward J Iii EVP, Chief Financial Officer |
67 429 Value: $680.4K |
||
|
Mar 01, 2025 Buy |
Dulac Edward J Iii EVP, Chief Financial Officer |
47 200 Value: $614.5K |
||
|
Mar 01, 2025 Buy |
Leonard John M President And CEO |
196 000 Value: $1.98M |
||
|
Mar 01, 2025 Buy |
Leonard John M President And CEO |
136 000 Value: $1.77M |
||
|
Mar 01, 2025 Buy |
Clark Eliana EVP, Chief Technical Officer |
45 714 Value: $461.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
